EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Biomarkers of neurodegenerative parkinsonisms: From current clinical to future biological definitions — literature review and our experience

Carla Brenlla, Carlos Lazaro-Hernandez, Manel Fernandez, Jesica Perez-Montesino, Lorena de Mena, Nuria Bargallo, Veronica Sanchez, Andres Perissinotti, Aida Niñerola-Baizan, Alexandra Perez-Soriano, Celia Painous, Ana Cámara und 1 weitere

Neurologia i Neurochirurgia Polska · 2025

DOI: 10.5603/pjnns.104070 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neurologia i Neurochirurgia Polska, 2025. Verfasst von Carla Brenlla und 12 weiteren Autor:innen. Beteiligte Einrichtung: Parkinson's Disease & Movement Disorders Unit, Neurology Service, Hospital Clinic University of Barcelona, UBNeuro Institute (Maria de Maeztu Excelle…. Hauptthemen laut MEDLINE: Biomarkers, Parkinson Disease, Neurodegenerative Diseases, Parkinsonian Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over recent decades, the search for sensitive and specific biomarkers of degenerative parkinsonisms has intensified. So also has the number of clinical trials aimed at disease modification and the subsequent need for improved recruitment of participants in the earliest possible stages and with the highest diagnostic certainty. Also increasing in number have been searches for ways to determine target engagement and biological effect, along with tracking of disease progression or its modification. With post mortem neuropathological confirmation remaining the most definite diagnostic category for most conditions, the updated diagnostic criteria are slowly introducing some routine biomarkers as supportive tools, mostly related to symptoms such as loss of smell in Parkinson’s Disease (PD) or demonstration of REM sleep behaviour disorders in both PD and multiple system atrophy (MSA), or structural or functional (chiefly dopaminergic) imaging, which sometimes lacks either sensitivity or specificity [specific MRI signs for MSA or progressive supranuclear palsy (PSP)]. However, potential new tools such as seed amplification assays (SAAs) and PET imaging of underlying alpha-synuclein and 4R-tau pathologies, while not without their own challenges, are being increasingly seen as the next generation of diagnostic tools. In this setting, proposals to biologically define these conditions, primarily for research purposes (which might eventually include clinical trials) are emerging. In this review, we aimed to overview of the current use of routine biomarkers and any future promise of biological definition by molecular markers tracking underlying pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersParkinson DiseaseNeurodegenerative DiseasesParkinsonian DisordersHumansMultiple System Atrophyalpha-Synuclein

Stichwörter der Autor:innen

CSFPD-MSAPSP-CBDbiomarkersbloodmolecular/functional imagingskinstructural neuroimaging

Substanzen

Biomarkersalpha-Synuclein

Autor:innen und Institutionen

  • Parkinson's Disease & Movement Disorders Unit, Neurology Service, Hospital Clinic University of Barcelona, UBNeuro Institute (Maria de Maeztu Excellence Centre), University of Barcelona, Barcelona, Spain.
  • Image Diagnosis Centre, Neuroradiology Section, Radiology Department, Hospital Clinic of Barcelona, Institut d'Investigacions Biome ̀diques August Pi I Sunyer, University of Barcelona, Barcelona, Spain.
  • Nuclear Medicine Service, Hospital Clinic of Barcelona, Biomedical Research Networking Centre of Bioengineering, Biomaterials and Nanomedicine, Barcelona, Spain.
  • Parkinson's Disease & Movement Disorders Unit, Neurology Service, Hospital Clinic University of Barcelona, UBNeuro Institute (Maria de Maeztu Excellence Centre), University of Barcelona, Barcelona, Spain. ycompta@clinic…

ORCID-Profile: Yaroslau Compta

Zitieren

APA

Brenlla, C., Lazaro-Hernandez, C., Fernandez, M., Perez-Montesino, J., de Mena, L., Bargallo, N., Sanchez, V., Perissinotti, A., Niñerola-Baizan, A., Perez-Soriano, A., Painous, C., Cámara, A., & Compta, Y. (2025). Biomarkers of neurodegenerative parkinsonisms: From current clinical to future biological definitions — literature review and our experience. Neurologia i Neurochirurgia Polska. https://doi.org/10.5603/pjnns.104070

Vancouver

Brenlla C, Lazaro-Hernandez C, Fernandez M, Perez-Montesino J, de Mena L, Bargallo N, et al. Biomarkers of neurodegenerative parkinsonisms: From current clinical to future biological definitions — literature review and our experience. Neurologia i Neurochirurgia Polska. 2025. doi:10.5603/pjnns.104070

BibTeX
@article{Brenlla2025,
  author = {Brenlla, Carla and Lazaro-Hernandez, Carlos and Fernandez, Manel and Perez-Montesino, Jesica and de Mena, Lorena and Bargallo, Nuria and Sanchez, Veronica and Perissinotti, Andres and Niñerola-Baizan, Aida and Perez-Soriano, Alexandra and Painous, Celia and Cámara, Ana and Compta, Yaroslau},
  title = {Biomarkers of neurodegenerative parkinsonisms: From current clinical to future biological definitions — literature review and our experience},
  journal = {Neurologia i Neurochirurgia Polska},
  year = {2025},
  doi = {10.5603/pjnns.104070}
}
Kostenlos starten →